CORTEX is a premier international journal published by Elsevier Masson, focusing on the cutting-edge areas of cognitive neuroscience, psychology, and neurology. With an impressive impact factor that places it in Q1 quartiles across multiple categories such as Cognitive Neuroscience and Neuropsychology, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 1964, CORTEX has continued to excel in disseminating high-quality scholarly work, offering insights that significantly enhance our understanding of the brain's functioning and behavior. Although not an open-access publication, it provides various access options to ensure the dissemination of knowledge is as wide-reaching as possible. As the field of cognitive psychology evolves, CORTEX remains at the forefront, fostering an environment for interdisciplinary collaboration and innovation. Researchers seeking to stay engaged with the latest advancements will find CORTEX an indispensable tool for their professional development.

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

NEUROTOXICITY RESEARCH is a premier journal published by SPRINGER, focusing on the critical and evolving field of neurotoxicology. With an ISSN of 1029-8428 and an E-ISSN of 1476-3524, this journal serves as a vital platform for researchers, professionals, and students dedicated to understanding the impact of toxic substances on nervous system health. Established in 1999, NEUROTOXICITY RESEARCH has consistently contributed significant findings and discussions that influence both theoretical and applied neuroscience. The journal's impressive Q2 ranking in both Neuroscience (miscellaneous) and Toxicology categories, alongside its strong percentile rankings in Scopus, underscores its relevance and quality in the academic community. While this journal is not open access, it remains a critical resource for those seeking interdisciplinary insights into the mechanisms of neurotoxicity. The objective of NEUROTOXICITY RESEARCH is to elucidate the intricate interactions between environmental and chemical agents and their neurotoxic effects, guiding future research and policies aimed at safeguarding neurological health. Based in the United States at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, this journal is committed to advancing the understanding of neurotoxic mechanisms and fostering collaborative efforts within the scientific community.

DEVELOPMENTAL NEUROPSYCHOLOGY (ISSN: 8756-5641; E-ISSN: 1532-6942) is a pivotal peer-reviewed journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD in the United Kingdom. Since its inception in 1985, this esteemed journal has been dedicated to advancing the understanding of developmental processes that influence neuropsychological outcomes in children and adolescents. With a focus on the integration of psychological and neuropsychological perspectives, it serves as a vital resource for researchers, clinicians, and educators alike. The journal's current impact factor and its placement in the third quartile for both Developmental and Educational Psychology and Neuropsychology categories underscore its significance in the field, as it ranks in the 45th percentile in both Scopus ranks. While DEVELOPMENTAL NEUROPSYCHOLOGY does not offer open access, it presents crucial research findings and theoretical advancements that cater to professionals seeking to deepen their knowledge and application of developmental neuropsychology until 2024. By fostering dialogue among scholars and practitioners, this journal contributes meaningfully to the ongoing evolution of clinical practices and educational strategies targeting neurodevelopmental trajectories.

Frontiers in Toxicology, published by Frontiers Media SA, is a prominent open-access journal dedicated to advancing the understanding of toxicological science. Established in 2019, it serves as a vital forum for innovative research, offering insights into the pharmacological impacts and toxicological profiles of various substances. With its international reach based in Switzerland, this journal has quickly ascended in the academic community, achieving a notable Q1 ranking in Pharmacology, Toxicology and Pharmaceutics (Miscellaneous) and a Q2 ranking in Toxicology as of 2023. The journal is indexed in Scopus, where it ranks #8 out of 43 in its primary category, underscoring its influence and relevance in the field. The scope encompasses cutting-edge studies on the mechanisms of toxicity, including both human and environmental impacts, making it an essential resource for researchers, professionals, and students alike. By promoting open access to high-quality research, Frontiers in Toxicology plays a crucial role in enhancing knowledge sharing and fostering collaboration across disciplines.

Drug and Chemical Toxicology is a well-respected journal in the fields of toxicology, pharmacology, and public health, published by Taylor & Francis Ltd. Since its inception in 1978, this journal has diligently explored the effects and mechanisms of chemical exposures on health and the environment, fulfilling a crucial role in advancing scientific understanding and safeguarding public health. The journal is indexed across prestigious databases and features an impressive array of articles categorized within the Q2 and Q3 quartiles across various categories in 2023, reflecting its significance in Chemical Health and Safety as well as Environmental and Occupational Health disciplines. With an extensive reach and a focus on interdisciplinary research, Drug and Chemical Toxicology offers a rich repository of original research, reviews, and methodological advancements, catering to a diverse audience of researchers, professionals, and students dedicated to the betterment of safety and health standards. Although not an open-access publication, its articles are widely accessible to the academic community, ensuring that critical innovations and insights are shared for the greater good.

Birth Defects Research is a premier open-access academic journal published by WILEY, dedicated to advancing the field of developmental biology and embryology, with an emphasis on understanding the mechanisms and factors influencing congenital anomalies. Since its establishment, the journal serves as a vital resource for researchers, professionals, and students alike, providing a platform for innovative research and insights in areas including pediatrics, toxicology, and health science. With an impact factor reflecting its commitment to quality, it is positioned in the Q2 and Q3 quartiles across several categories for 2023, demonstrating its relevance and influence within the scientific community. Researchers will find it particularly valuable for disseminating findings and encouraging interdisciplinary collaboration in combatting birth defects and improving child health outcomes. Accessible from the United Kingdom, the journal fosters the free exchange of information, reinforcing its goal to support the global health landscape through knowledge and innovation.

Review Journal of Autism and Developmental Disorders, published by Springer Heidelberg, stands as a leading platform for the dissemination of groundbreaking research in the realm of autism and developmental disorders. With an ISSN of 2195-7177 and an E-ISSN of 2195-7185, this journal not only showcases high-quality research but also emphasizes the crucial intersections between behavioral neuroscience, cognitive neuroscience, developmental neuroscience, and psychiatry. Notably, the journal has achieved a prestigious Q1 ranking across these categories, reflecting its impact and relevance; it ranks 10th in behavioral neuroscience and 5th in developmental neuroscience within Scopus metrics. Spanning from 2014 to 2024, the journal is dedicated to fostering a deeper understanding of autism spectrum disorders and related conditions, making it indispensable for researchers, clinicians, and students alike. While it operates under a traditional access model, the quality of the peer-reviewed articles ensures that it remains a valuable resource in the academic community.

COGNITIVE NEUROPSYCHOLOGY, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a premier academic journal that has established itself as a vital resource in the fields of cognitive neuroscience, neuropsychology, and psychology since its inception in 1984. With an esteemed impact factor that reflects its significance within the academic community, this journal is classified in the Q1 category for Arts and Humanities (miscellaneous) and Q2 in various other fields, including Cognitive Neuroscience and Developmental Psychology, based on the latest evaluation of 2023. COGNITIVE NEUROPSYCHOLOGY provides a platform for the dissemination of innovative research findings and theoretical advancements that deepen our understanding of cognitive processes and behavior in relation to neural systems. The journal also boasts a robust Scopus ranking, ensuring that articles published are of the highest caliber. Though it follows a traditional publishing model, the journal's commitment to rigorous peer review guarantees that it remains an authoritative voice for researchers, professionals, and students devoted to advancing knowledge in these critical areas of study.

DEVELOPMENTAL NEUROSCIENCE, published by KARGER, is a vital academic journal dedicated to advancing the field of neurodevelopmental research. Since its inception in 1978, this journal has been instrumental in disseminating high-quality studies that explore the complexities of brain development and function throughout the lifespan. With an impact factor that places it in the second quartile (Q2) of Developmental Neuroscience and Neurology categories, it ranks among the top publications in its field, offering valuable insights for researchers, clinicians, and students alike. Though primarily subscription-based, the journal remains committed to fostering academic discourse and collaboration through its extensive repository of original research articles, reviews, and case studies. The journal is located at ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND, and its scope spans critical areas of inquiry within developmental neurology, providing a platform for emerging ideas and methodologies. As such, DEVELOPMENTAL NEUROSCIENCE serves not only as a critical resource for seasoned professionals but also as an enriching educational tool for the next generation of neuroscientists.